University of Wisconsin–Madison

(TCAD) A Phase 2 multi-center, randomized, double blind, placebo controlled, parallel group study to evaluate the efficacy and safety of T-817MA in patients with mild to moderate Alzheimer’s Disease

The PI of this project is: Sanjay Asthana MD

This project is funded by:

The term of this project is: August 2014 to April 2016

The number of subjects scanned during this project is: 12